China Growth Stocks

[GorillaGorilla]

CHME

The amount of dilution going on in confusing. They also said that the reduced working capital could affect the upcoming quarter.

Against that they have the catalyst of rADTZ drug and the sinofrom aquisition (which is the reasons for the reduced working capital).

It looks a winner so I have a few shares but in the back of my mind I keep thinking of all the chinese companies that muck up financing. There's a lot of financing to be done here.

If they got some financing out of the way and I can see they did it properly I would be more confident. Also... small volume and wide spread... would be nice to have more liquidity.

Anyways, that's my take. Don't know what others think?

rich